Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Morningside Technology Ventures

Founders Qin Liu

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 87
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 76
Rounds per year 2.29
Lead investments 28
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 6
Key employees 5

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

The main office of represented VC is situated in the Shanghai. The fund was located in Asia if to be more exact in China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Morningside Technology Ventures, startups are often financed by University Ventures, Morningside Group, Top Line Growth Capital. The meaningful sponsors for the fund in investment in the same round are University Ventures, Tamarisc Ventures, Topline Capital. In the next rounds fund is usually obtained by University Ventures, Tudor Growth Equity, The Exxel Group.

Among the most popular portfolio startups of the fund, we may highlight Rockley Photonics, Jitjatjo, Ignition Design Labs. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Education, Internet. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Morningside Technology Ventures works on 19 percentage points less the average amount of lead investments. The top activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Morningside Technology Ventures:
Typical Co-investors
Morningside Technology Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Morningside Technology Ventures:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Century Financial Partners -
Even China, Jiangsu, Suzhou
Fomocraft Ventures -
Osprey Capital Illinois, United States, Wilmette
Rivington Capital Partners Houston, Texas, United States
Sino Biopharmaceutical China, Hong Kong, Hong Kong Island
Sony Music Entertainment New York, New York, United States
Toyo Engineering Chiba, Chiba Prefecture, Japan
Trentino Sviluppo -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Xencore Network

11 May 2024 Haidian, Beijing, China

ENYO Pharma

Biopharma
Biotechnology
Medical
$46M03 Jan 2024 Lyon, Auvergne-Rhône-Alpes, France

Epigenic Therapeutics

Biotechnology
$32M29 Aug 2023 Shanghai, Shanghai, China

GaeaStar

Environmental Engineering
GreenTech
Manufacturing
Sustainability
$6M06 Apr 2023 Berlin, Berlin, Germany

Phage Pharm

Biotechnology
Pharmaceutical
$13M01 Mar 2023 Qingdao Shi, Shandong, China

Zhide New Energy

01 Jan 2023 Jinhua, Zhejiang, China

Resilience Lab

Health Care
Personal Health
Psychology
Therapeutics
Wellness
$15M17 Nov 2022 New York, New York, United States

Valitor

Biotechnology
Developer Tools
Medical
Therapeutics
$28M05 Oct 2022 Berkeley, California, United States

AdvanCell

Biotechnology
Clinical Trials
Pharmaceutical
$13M23 Aug 2022 Sydney, New South Wales, Australia
News
Hummingbird Bioscience Raises US$125M in Series C Financing

– Hummingbird Bioscience from Singapore develops precision therapies against hard-to-drug targets to improve treatment outcomes.
– Series C $125m round brings company valuation to more than $1b.
– The round was led by Novo Holdings with participation from new investors – Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, DROIA Ventures, Morningside Ventures, Pureos Bioventures, Polaris Partners, Affinity Asset Advisors, Ally Bridge Group and Altrium Capital Management and existing investors SK Inc, Heritas Capital, and Mirae Asset Venture Capital.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Morningside Technology Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 87
Average round size 35M
Rounds per year 2.29
Peak activity year 2021
Lead investments 28
Follow on index 0.13
Exits 6
Group Appearance index 0.60

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Xencore Network

11 May 2024 Haidian, Beijing, China

ENYO Pharma

Biopharma
Biotechnology
Medical
$46M03 Jan 2024 Lyon, Auvergne-Rhône-Alpes, France

Epigenic Therapeutics

Biotechnology
$32M29 Aug 2023 Shanghai, Shanghai, China

GaeaStar

Environmental Engineering
GreenTech
Manufacturing
Sustainability
$6M06 Apr 2023 Berlin, Berlin, Germany

Phage Pharm

Biotechnology
Pharmaceutical
$13M01 Mar 2023 Qingdao Shi, Shandong, China

Zhide New Energy

01 Jan 2023 Jinhua, Zhejiang, China

Resilience Lab

Health Care
Personal Health
Psychology
Therapeutics
Wellness
$15M17 Nov 2022 New York, New York, United States

Valitor

Biotechnology
Developer Tools
Medical
Therapeutics
$28M05 Oct 2022 Berkeley, California, United States

AdvanCell

Biotechnology
Clinical Trials
Pharmaceutical
$13M23 Aug 2022 Sydney, New South Wales, Australia
Crunchbase icon

Content report

The following text will be sent to our editors: